Surgery for hepatocellular carcinoma can provide the same life-expectancy as transplant of that of general population
When deciding for the optimal treatment to adopt in patients suffering from hepatocellular carcinoma (HCC), the surgical approach is commonly considered as the most curative option (1,2). The scarcity of donors for liver transplantation (LT) led surgeons to bridge patients until an eventual future transplant (salvage LT), opting in first instance and when feasible for hepatic resection (HR) also for those patients otherwise transplantable (2). In the study published by Pinna and colleagues in Annals of Surgery 2018, it was verified in what measure LT and HR can provide for HCC the same mortality expected in the general population, defining the so called "statistical cure" (3).
8
2019-07-17（万方平台首次上网日期，不代表论文的发表时间）
共2页
151-152
